Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Nasopharyngeal microbiome composition by SARS-CoV-2 presence and severity

ABSTRACT: Nasopharyngeal microbiome

PROVIDER: PRJEB77696 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR13373100_1.fastq.gz	Fastqsanger.gz
	ERR13373100_2.fastq.gz	Fastqsanger.gz
	ERR13373200_1.fastq.gz	Fastqsanger.gz
	ERR13373200_2.fastq.gz	Fastqsanger.gz
	ERR13373101_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 342

Similar Datasets

Nasopharyngeal microbiome composition by SARS-CoV-2 presence and severity

Project description:Nasopharyngeal microbiome

| PRJEB77685 | ENA

Nasopharyngeal microbiome composition by SARS-CoV-2 presence and severity

Project description:Nasopharyngeal microbiome

| PRJEB77698 | ENA

SARS-CoV-2 Oropharyngeal and Nasopharyngeal samples

Project description:Microbiome analysis of oropharyngeal and nasopharyngeal samples of SARS-CoV-2 infected patients

2021-02-06 | GSE166281 | GEO

Host nasopharyngeal transcriptome analysis in a SARS-CoV-2 positive Italian cohort

Project description:The ongoing COVID-19 pandemic caused by SARS-CoV-2 has affected millions of people worldwide and has significant implications for public health. Host transcriptomics profiling provides comprehensive understanding of how the virus interacts with host cells and how the host responds to the virus. COVID-19 disease alters the host transcriptome, affecting cellular pathways and key molecular functions. To contribute to the global effort to understand the virus’s effect on host cell transcriptome, we have generated a dataset from nasopharyngeal swabs of 35 individuals infected with SARS-CoV-2 from the Campania region in Italy during the three outbreaks, with different clinical conditions. This dataset will help to elucidate the complex interactions among genes and can be useful in the development of effective therapeutic pathways

2023-05-25 | E-MTAB-13028 | biostudies-arrayexpress

Nasopharyngeal microbiome of SARS-CoV-2 infected and non infected individuals

Project description:Nasopharyngeal microbiome of SARS-CoV-2 infected and non infected individuals Raw sequence reads

| PRJNA707350 | ENA

Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.

Project description:ObjectivesThe COVID-19 pandemic and ensuing public health emergency has emphasized the need to study SARS-CoV-2 pathogenesis. The human microbiome has been shown to regulate the host immune system and may influence host susceptibility to viral infection, as well as disease severity. Several studies have assessed whether compositional alterations in the nasopharyngeal microbiota are associated with SARS-CoV-2 infection. However, the results of these studies were varied, and many did not account for disease severity. This study aims to examine whether compositional differences in the nasopharyngeal microbiota are associated with SARS-CoV-2 infection status and disease severity.MethodsWe performed Nanopore full-length 16S rRNA sequencing on 194 nasopharyngeal swab specimens from hospitalized and community-dwelling SARS-CoV-2-infected and uninfected individuals. Sequence data analysis was performed using the BugSeq 16S analysis pipeline.ResultsWe found significant beta (PERMANOVA p < 0.05), but not alpha (Kruskal-Wallis p > 0.05) diversity differences in the nasopharyngeal microbiota among our study groups. We identified several differentially abundant taxa associated with SARS-CoV-2 infection status and disease severity using ALDEx2. Finally, we observed a trend towards higher abundance of Enterobacteriaceae in specimens from hospitalized SARS-CoV-2-infected patients.ConclusionsThis study identified several alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity. Understanding the role of the microbiome in infection susceptibility and severity may open new avenues of research for disease prevention and treatment.

| S-EPMC9565700 | biostudies-literature

Noninvasive Nasopharyngeal Proteomics Identify Coagulation Abnormalities in SARS-CoV-2

Project description:Vaccines/drugs that could utilize the mucosal immune system to produce antibodies in the nose should help stop the coronavirus at the point of entry. Therefore, Identification of biomarkers in nasal microenvironment associated with viral clearance, vaccine implementation, and easily measurable correlates of protection, can allow monitoring of infection-induced immunity and facilitate novel drug/vaccine development. Our study proposes to use mass spectrometry-based proteomics to reflect the host response to COVID-19 infection in the nasopharyngeal environment and to identify any new biomarkers that can be used for designing non-invasive prognostic tools and treatments at the point of entry of the virus.

2022-07-21 | PXD029143 | Pride

Nasopharyngeal microbiome

Project description:Impact of Streptococcus salivarius K12 on the otitis media pathogens in the nasopharyngeal microbiome

| PRJNA603433 | ENA

Proteome Map of Human nasopharyngeal/oropharyngeal swab samples in VTM media following SARS-CoV-2 infection

Project description:A detailed proteomic analysis of the nasopharyngeal/oropharyngeal swab samples collected from normal individuals and individuals infected with SARS-CoV-2 involving high throughput quantitative (iTRAQ) proteomics analysis.

2022-12-22 | PXD032150 | Pride

SARS-CoV-2 Oropharyngeal and Nasopharyngeal samples

Project description:SARS-CoV-2 Oropharyngeal and Nasopharyngeal samples

| PRJNA699908 | ENA